DEA Update 2015
Tuesday, October 13, 2015, 2:45 p.m. - 4:15 p.m.
Gaylord National Resort and Convention Center
Continuing Education Credits: 0.15 (1.5 Contact Hours)
ACPE #: 207-000-15-137-L04-P and ACPE #: 207-000-15-137-L04-T
To say that compliance with DEA regulations in your community pharmacy is important would be a huge understatement, the impact of a DEA audit on your business could be critical. This session will provide very timely updates from the Chief of Liaison & Policy Section, Office of Diversion Control at DEA on actions to address prescription drug abuse and diversion, electronic prescribing of controlled substances, drug disposal, registration fees, inspections and controlled substance monitoring, and strategies for pharmacists to use to comply with the corresponding responsibility rule for verifying prescriptions.
Pharmacist and Pharmacy Technician Learning Objectives:
Discuss the scope of the prescription drug abuse problem in the United States.
Identify ways that prescription controlled substances are being diverted from the pharmaceutical supply chain.
Identify areas where DEA, local law enforcement and pharmacists can work together to curb prescription drug abuse.
Identify common "red flags" that pharmacists should be on the lookout for regarding errant prescribing, forgeries and recipient drug seeking behavior.
Speaker: Ruth Carter, Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice, Washington DC
Activity Type: Application-based
Audience: Pharmacists and Pharmacy Technicians